Abstract
Purpose
To determine the effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children.
Methods
All of the HIV-infected children attending the Institute of Pediatrics, University of Milan, Milan, Italy, between 1982 and 2004 were studied. Every 3 months, they were physically examined and underwent indirect fundoscopy conducted by an experienced ophthalmologist; if diagnosed as having eye disease, they were evaluated by the ophthalmologist every week while on specific therapy and monthly thereafter. The clinical and laboratory findings before and after the introduction of HAART were compared.
Results
The cohort consisted of 117 HIV-infected children (61 males), with a follow-up ranging from 0.09 to 22.31 years (median, 16.33 years). A total of nine cases of ocular involvement (7.7%) were diagnosed between 1983 and 1994, before the introduction of HAART. All nine children died 4–24 months (median, 15 months) after the diagnosis of ophthalmic disease. No case of ocular involvement was observed after the introduction of HAART (P=0.011 vsbefore HAART).
Conclusion
The introduction of HAART has had a significant impact on the natural history of ocular manifestations in HIV-infected children, thus suggesting that a reduction in the frequency of ophthalmologic follow-up should be considered for HAART-treated HIV-infected children with immune reconstitution and no visual symptom.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Robinson MR, Ross ML, Whitcup SM . Ocular manifestations of HIV infection. Curr Opin Ophthalmol 1999; 10: 431–437.
Moraes Jr HV . Ocular manifestations of HIV/AIDS. Curr Opin Ophthalmol 2002; 13: 397–403.
Wren SME, Fielder AR, Bethell D, Lyall EGH, Tudor-Williams G, Cocker KD et al. Cytomegalovirus retinitis in infancy. Eye 2004; 18: 389–392.
Kahraman G, Krepler K, Franz C, Ries E, Maar N, Wedrich A et al. Seven years of HAART impact on ophthalmic management of HIV-infected patients. Ocul Immunol Inflamm 2005; 13: 213–218.
Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362: 22–29.
Jabs DA, Holbrook JT, Van Natta ML, Clark R, Jacobson MA, Kempen JH et al. Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology 2005; 112: 771–779.
Deayton J, Wilson P, Sabin CA, Davey CC, Johnson MA, Emery VC et al. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy. AIDS 2000; 14: 1163–1170.
Lin DY, Warren JF, Lazzeroni LC, Wolitz RA, Mansour SE . Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV-infected patients. Retina 2002; 22: 268–277.
Ng WT, Versace P . Ocular association of HIV infection in the era of highly active antiretroviral therapy and the global perspective. Clin Exp Ophthalmol 2005; 33: 317–329.
Goldberg DE, Smithen LM, Angelilli A, Freeman WR . HIV-associated retinopathy in the HAART era. Retina 2005; 25: 633–649.
French MA, Price P, Stone SF . Immune restoration disease after antiretroviral therapy. AIDS 2004; 18: 1615–1628.
Miserocchi E, Modorati G, Brancato R . Immune recovery uveitis in an iatrogenically immunosuppressed patient. Eur J Ophthalmol 2005; 15: 510–512.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was conducted in accordance with the guidelines for human experimentation specified by the authors' institution
Presented in part at the 23rd Annual Meeting of the European Society for Paediatric Infectious Diseases-ESPID, Valencia, Spain, 18–20 May 2005
Rights and permissions
About this article
Cite this article
Esposito, S., Porta, A., Bojanin, J. et al. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children. Eye 20, 595–597 (2006). https://doi.org/10.1038/sj.eye.6702189
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6702189
